Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Zhonghua Zhong Liu Za Zhi ; 42(3): 187-191, 2020 Mar 23.
Article in Chinese | MEDLINE | ID: covidwho-590726

ABSTRACT

Objective: From December 2019, the new coronavirus pneumonia (COVID-19) broke out in Wuhan, Hubei, and spread rapidly to the nationwide. On January 20, 2020, the National Health Committee classified COVID-19 pneumonia as one of B class infectious diseases and treated it as class A infectious disease. During the epidemic period, the routine diagnosis and treatment of tumor patients was affected with varying degrees. In this special period, we performed the superiority of the multi-disciplinary team of diagnosis and treatment, achieved accurate diagnosis and treatment of patients with hepatobiliary malignant tumors, provided support for these patients with limited medical resources, and helped them to survive during the epidemic period.On the basis of fully understanding the new coronavirus pneumonia, the treatment strategy should be changed timely during the epidemic, and more appropriate treatment methods should be adopted to minimize the adverse effect of the epidemic on tumor treatment.


Subject(s)
Coronavirus Infections/prevention & control , Coronavirus , Cross Infection/prevention & control , Liver Neoplasms/surgery , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Betacoronavirus , Biliary Tract Neoplasms/diagnosis , COVID-19 , China , Communicable Disease Control/methods , Coronavirus/pathogenicity , Coronavirus Infections/epidemiology , Disease Outbreaks , Humans , Immunocompromised Host , Liver Neoplasms/diagnosis , Patient Care Planning , Pneumonia, Viral/epidemiology , Risk , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL